EX-23.1 3 exhibit23-1.htm EXHIBIT 23.1 Trillium Therapeutics Inc.: Exhibit 23.1 - Filed by newsfilecorp.com

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption "Experts" in this Registration Statement (Form F-3) and related Prospectus of Trillium Therapeutics Inc., and to the incorporation by reference therein of our report dated March 5, 2020 with respect to the consolidated financial statements of Trillium Therapeutics Inc., included in its Annual Report (Form 40-F) for the year ended December 31, 2019, filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP

Toronto, Canada

Chartered Professional Accountants

April 23, 2020

Licensed Public Accountants